The catalepsy test: Its ups and downs.

Paul R. Sanberg, Michael D. Bunsey, Magda Giòrdano, Andrew B. Norman·1988·Behavioral Neuroscience

Cites (36)

  1. Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
    Creese, Ian, Burt, David R., Snyder, Solomon H. · 1976 · Science
  2. Antipsychotic drug doses and neuroleptic/dopamine receptors
    SEEMAN, P., LEE, T., CHAU-WONG, M., WONG, K. · 1976 · Nature
  3. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.
    Iorio, L C, Barnett, A, Leitz, F H, Houser, V P, Korduba, C A · 1983 · The Journal of Pharmacology and Experimental Therapeutics
  4. Clinical Chemistry : Theory, Analysis, Correlation
    Lawrence A. Kaplan, Amadeo J. Pesce · 1996 · Medical Entomology and Zoology
  5. Pharmacology and Therapeutics.
    1886 · The Lancet
  6. Morphine catalepsy in the rat: relation to striatal dopamine metabolism
    Kuschiski, K., Hornykiewicz, O. · 1972 · European Journal of Pharmacology
  7. Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors
    Sanberg, Paul R. · 1980 · Nature
  8. Morphine versus haloperidol catalepsy in the rat: A behavioral analysis of postural support mechanisms
    De Ryck, Marc, Schallert, Timothy, Teitelbaum, Philip · 1980 · Brain Research
  9. Serotonin-dopamine interactions in the nigrostriatal system
    Waldmeier, Peter C., Delini-Stula, Alexandra A. · 1979 · European Journal of Pharmacology
  10. On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity
    Costall, B., Naylor, R. J. · 1974 · Psychopharmacologia
  11. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Ellen J. Hess, Lawrence J. Albers, H Le, Ian Creese · 1986 · Journal of Pharmacology and Experimental Therapeutics
  12. Lesions in corpus striatum and cortex of rat brains and the effect on pharmacologically induced stereotyped, aggressive and cataleptic behaviour
    R. Fog, Axel A. Randrup, Henning Pakkenberg · 1970 · Psychopharmacology
  13. Scientific approaches to Huntington's disease.
    Sanberg Pr, JOSEPH T. COYLE · 1984 · PubMed
  14. Tolerance to haloperidol catalepsy
    Cheryl Ezrin‐Waters, Philip M. Seeman · 1977 · European Journal of Pharmacology
  15. Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors
    Hess Ej, AB Norman, Ian Creese · 1988 · Journal of Neuroscience
  16. Evidence for a cholinergic role in haloperidol-induced catalepsy
    William R Klemm · 1985 · Psychopharmacology
  17. Behavioural dissociation of the enkephalinergic systems of nucleus accumbens and nucleus caudatus
    Russell E. Dill, E. Costa · 1977 · Neuropharmacology
  18. Neurochemical aspects of the opioid-induced ‘catatonia’
    Ursula Havemann‐Reinecke, Klaus Kuschinsky · 1982 · Neurochemistry International
  19. Body pinch induces long lasting cataleptic like immobility in mice: behavioral characterization and the effect of naloxone.
    Shimon Amir, Zavie W. Brown, Z. Amit, Kurt Ornstein · 1981 · Life Science
  20. The role of the corpus striatum in neuroleptic- and narcotic-induced catalepsy
    Kenneth B. Koffer, S. Berney, Oleh Hornykiewicz · 1978 · European Journal of Pharmacology
  21. Tetrahydrocannabinol potentiates reserpine-induced hypokinesia
    Donald E. Moss, Suzanne B. McMaster, Joseph Rogers · 1981 · Pharmacology Biochemistry and Behavior
  22. Cerebrospinal fluid homovanillic acid patterns during neuroleptic treatment
    Malcolm B. Bowers, George R. Heninger · 1981 · Psychiatry Research
  23. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy
    Stephen F. Calderon, Paul R. Sanberg, Andrew B. Norman · 1988 · Brain Research
  24. Kainic acid injections in the striatum alter the cataleptic and locomotor effects of drugs influencing dopaminerig and cholinergic systems
    Paul R. Sanberg, Michelle Pisa, Hans C. Fibiger · 1981 · European Journal of Pharmacology
  25. Predictability and specificity of behavioral screening tests for nucleoleptics
    P. Worms, Kenneth G. Lloyd · 1979 · Pharmacology & Therapeutics
  26. Unilateral injection of morphine into the nucleus accumbens induces akinesia and catalepsy, but no spontaneous muscular rigidity in rats
    Moritz Winkler, Ursula Havemann‐Reinecke, Klaus Kuschinsky · 1982 · Naunyn-Schmiedeberg s Archives of Pharmacology
  27. The Basal ganglia
    Melvin D. Yahr, Mental Disease · 1976 · Medical Entomology and Zoology
  28. Cholinergic-dopaminergic interactions in experimental catalepsy
    William R Klemm · 1983 · Psychopharmacology
  29. Potentiation by haloperidol of the catalepsy produced by lesions in the parafascicular nucleus of the rat
    S. Ahlenius · 1978 · Brain Research
  30. Tissue levels of haloperidol by radioreceptor assay and behavioral effects of haloperidol in the rat
    Alexander Campbell, Michael Herschel, Bruce M. Cohen, Ross J. Baldessarini · 1980 · Life Sciences
  31. Morphine catalepsy as an adaptive reflex state in rats.
    Marc De Ryck, Philip Teitelbaum · 1984 · Behavioral Neuroscience
  32. Experimental catalepsy is both enhanced and disrupted by apomorphine
    William R Klemm · 1985 · Psychopharmacology
  33. TOLERANCE AND REVERSE TOLERANCE TO HALOPERIDOL CATALEPSY INDUCED BY THE DIFFERENCE OF ADMINISTRATION INTERVAL IN MICE
    Yoshikatsu Masuda, Shigeo Murai, Tadanobu Itoh · 1982 · The Japanese Journal of Pharmacology
  34. Is morphine-induced catalepsy related to activation of dopaminergic neurones?
    Peter Moleman, Dennis Versluis, Jacques Bruinvels · 1978 · Psychopharmacology
  35. Effect of sensory stimulation on the potency of cataleptogens
    A. D. Ariyanayagam, Sheila L. Handley · 1975 · Psychopharmacology
  36. The development of catalepsy in drug-free mice on repeated testing
    JANET H. BROWN, Sheila L. Handley · 1980 · Neuropharmacology

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.